BioMarin Pharmaceutical Inc (BMRN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:BioMarin Pharmaceutical Inc (BMRN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013831
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals that treat serious diseases and medical conditions. The company offers products for the treatment of various diseases such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product portfolio consists of products and multiple clinical and preclinical product candidates. The company operates through its manufacturing facilities in Novato, California and has its presence in US, Europe, Latin America, the Middle East, and Asia-Pacific. BioMarin is headquartered in San Rafael, California, the US.

BioMarin Pharmaceutical Inc (BMRN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioMarin Pharmaceutical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioMarin Pharmaceutical Inc, Medical Equipment, Deal Details 10
Partnerships 10
Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 10
Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay 11
Equity Offering 12
BioMarin Pharma Prices Public Offering of Shares for USD720 Million 12
BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million 13
Debt Offering 14
BioMarin Pharma Completes Underwriters Exercise of Over-Allotment Option of 0.599% Notes Due 2024 for USD45 Million 14
BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million 15
BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million 17
Acquisition 19
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion 19
BioMarin Pharma Acquires Zacharon Pharma For US$10 Million 20
BioMarin Pharmaceutical Inc – Key Competitors 21
BioMarin Pharmaceutical Inc – Key Employees 22
BioMarin Pharmaceutical Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Oct 26, 2017: BioMarin Announces Third Quarter 2017 Financial Results 25
Aug 02, 2017: BioMarin Announces Second Quarter 2017 Financial Results 29
May 04, 2017: BioMarin Announces First Quarter 2017 Financial Results 31
Feb 23, 2017: BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results 33
Oct 27, 2016: BioMarin Announces Third Quarter 2016 Financial Results 35
Apr 28, 2016: BioMarin Announces First Quarter 2016 Financial Results 37
Feb 25, 2016: BioMarin Announces Fourth Quarter and Full Year 2015 Financial Results 39
Corporate Communications 41
Oct 03, 2017: BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors 41
Jul 18, 2016: BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and Kathryn E. Falberg 42
Jan 04, 2016: BioMarin Announces Addition of David Pyott, Former Allergan Chairman and CEO, to Company’s Board of Directors 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
BioMarin Pharmaceutical Inc, Medical Equipment, Key Facts, 2016 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioMarin Pharmaceutical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioMarin Pharmaceutical Inc, Deals By Market, 2011 to YTD 2017 8
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 10
Zacharon Pharma Enters Into Licensing Agreement With Arup Labs For Sensi-Pro Assay 11
BioMarin Pharma Prices Public Offering of Shares for USD720 Million 12
BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million 13
BioMarin Pharma Completes Underwriters Exercise of Over-Allotment Option of 0.599% Notes Due 2024 for USD45 Million 14
BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million 15
BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million 17
Roche Rumored To Acquire BioMarin Pharma For US$13.5 Billion 19
BioMarin Pharma Acquires Zacharon Pharma For US$10 Million 20
BioMarin Pharmaceutical Inc, Key Competitors 21
BioMarin Pharmaceutical Inc, Key Employees 22
BioMarin Pharmaceutical Inc, Other Locations 23
BioMarin Pharmaceutical Inc, Subsidiaries 23
BioMarin Pharmaceutical Inc, Joint Venture 24

★海外企業調査レポート[BioMarin Pharmaceutical Inc (BMRN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Frontage Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • Arete Industries Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Arete Industries Inc (Arete Industries) is an oil and gas company that operates pipeline stations. The company operates a natural gas gathering system located in Campbell County, Wyoming. Its gas gathering systems contains coated steel pipeline transporting coal bed methane. Arete Industries …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務分析
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報
    Summary Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based …
  • Rosneft Oil Co (ROSN):石油・ガス:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • Cigna Corp (CI):企業の財務・戦略的SWOT分析
    Cigna Corp (CI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • AmerisourceBergen Corp (ABC):製薬・医療:M&Aディール及び事業提携情報
    Summary AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company that provides pharmaceutical products, business solutions and value-driving services that improve access to care. The company distributes a broad offering of brand-name, specialty brand- …
  • WPPI Energy, Inc.:企業の戦略的SWOT分析
    WPPI Energy, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • CareCloud Corp:医療機器:M&Aディール及び事業提携情報
    Summary CareCloud Corp (CareCloud) is a healthcare technology company that offers cloud healthcare solutions. The company offers cloud-based healthcare IT solutions. It offers revenue cycle management, electronic health records, patient engagement, practice management, and others. CareCloud provides …
  • Abengoa SA (ABG)-エネルギー分野:企業M&A・提携分析
    Summary Abengoa, S.A. (Abengoa) is a manufacturer of applied engineering and equipment. The company provides integrated project solutions, including engineering and operation and maintenance services for conventional and renewable energy, infrastructure, and water desalination projects. Through long …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • PricewaterhouseCoopers International Limited:企業の戦略・SWOT・財務情報
    PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report Summary PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Pattern Energy Group Inc.:企業のM&A・事業提携・投資動向
    Pattern Energy Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pattern Energy Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Adisseo France SAS:企業の戦略的SWOT分析
    Adisseo France SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Antisense Therapeutics Ltd (ANP):製薬・医療:M&Aディール及び事業提携情報
    Summary Antisense Therapeutics Ltd (Antisense Therapeutics) is clinical staged biopharmaceutical company which focuses on the discovery, development and commercialization of second generation antisense pharmaceuticals for various medical conditions that have large unmet medical needs. It focuses on …
  • Arrowhead Pharmaceuticals Inc (ARWR):製薬・医療:M&Aディール及び事業提携情報
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, …
  • Abiomed Inc (ABMD)-医療機器分野:企業M&A・提携分析
    Summary Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for cir …
  • Alecta Pensionsforsakring Omsesidigt:企業の戦略的SWOT分析
    Alecta Pensionsforsakring Omsesidigt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vect-Horus SAS (Vect-Horus) is a biotechnology company that designs and develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into organs including the brain and tumors. The company combines molecules of interest to peptide-vectors that targets receptor mediate …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆